Named Vice President for Government Relations at ACLA in February 2004, he comes to ACLA from his position as Manager of Congressional and Regulatory Affairs at the American Society for Clinical Pathology (ASCP) where he worked from 2001 through 2004.   During his tenure with ASCP, he developed a knowledge base in pathology and laboratory medicine among other issues.   Prior to that position he was Government Affairs Coordinator at the American Society of Hematology.   Mr. DuBois has an MBA from George Mason University, a Master's of Arts degree from Miami University of Ohio, and a Bachelor's degree from Gettysburg College.

Jen Bowman is ACLA’s Vice President for Policy and Regulatory Affairs.  She counsels the nation’s leading clinical laboratories on issues that bridge health policy and business strategy.  She develops and advocates for the association’s regulatory and policy agenda. 

Jen has deep substantive expertise and over a decade of experience in health policy.  Prior to joining ACLA, she advised pharmaceutical clients on product positioning in the US and global markets with UK-based PRMA Consulting.  As a principal with the Podesta Group, she counseled health care clients on influencing strategies for health care reform and Medicare payment changes, advocating to the legislative and executive branches on their behalf.  

During seven years at Avalere Health LLC, Jen led many consulting engagements on the Medicare drug benefit, led the firm’s series of public conferences and audio conferences, and served on the leadership team.  Previously she worked for three years as a health analyst at the Congressional Budget Office, analyzing the economic impact of legislation on the federal budget and the private sector.

Jen earned a Master of Public Health degree from Yale University and a B.A. in Biochemistry from Rice University.

Peter M. Kazon is a senior counsel in Alston & Bird's Washington, D.C. office concentrating on health care law and policy. Peter counsels health care providers on regulatory issues, especially matters involving Medicare reimbursement, Stark self-referral, fraud and abuse, food and drug law and antitrust. He also specializes in advising clinical laboratories and companies furnishing diagnostic services and products on regulatory issues. He advises companies on compliance with the Food, Drug and Cosmetic Act and its recent amendments, including premarket approval and clearance requirements, and related coverage, coding and reimbursement issues. He has extensive experience in hospital staff privilege matters and in third-party payor and Medicare and Medicaid reimbursement issues. A frequent speaker on health care issues, Peter's recent presentations include: "Genetic Tests, Pharmacogenomics and Drug Development,"BIO 2004 (June 2004); "Protecting Electronic Health Data: The New HHS Security Requirements,"Beckman Coulter Symposia 2004 (May 2004); "Medical Necessity Denials, Policy Determinations and Appeals," Institute on Medicare and Medicaid Payment Issues Program, presented by the American Health Lawyers Association (March 2004); "Congress Approves Medicare Reform: What's The Bottom-Line For Labs, Pathologists & Hospitals in 2004?"Washington G-2 Reports (December 2003). He is the author of "Doing Business with the New Medicare — A Policy Guide for Clinical Laboratory Testing,"published by Washington G-2 Reports (2004). After receiving a B.A., magna cum laude, from Tufts University in 1975, Peter earned his J.D. from Temple University in 1978, where he served on the staff of the Temple Law Quarterly. Peter is admitted to practice in the District of Columbia, Massachusetts and Maine and is a member of the bar associations in each of those jurisdictions. He is also a member of the American Health Lawyers Association.